Wust, P., Hildebrandt, B., Sreenivasa, G., Rau, B., Gellermann, J., Riess, H., Schlag, P. M. (2002). Hyperthermia in combined treatment of cancer. The Lancet. Oncology, 3(8), 487–497. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12147435
Jones, E. L., Oleson, J. R., Prosnitz, L. R., Samulski, T. V., Vujaskovic, Z., Yu, D., Dewhirst, M. W. (2005). Randomized Trial of Hyperthermia and Radiation for Superficial Tumors. Journal of Clinical Oncology, 23(13), 3079–3085. https://doi.org/10.1200/JCO.2005.05.520
Hehr, T., Wust, P., Bamberg, M., & Budach, W. (2003). Current and Potential Role of Thermoradiotherapy for Solid Tumours. Oncology Research and Treatment, 26(3), 295–302. https://doi.org/10.1159/000071628
Falk, M. H., & Issels, R. D. (n.d.). Hyperthermia in oncology. International Journal of Hyperthermia: The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 17(1), 1–18. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11212876
Van der Zee, J. (2002). Heating the patient: a promising approach? Annals of Oncology, 13(8), 1173–1184. https://doi.org/10.1093/annonc/mdf280
Cihoric, N., Tsikkinis, A., van Rhoon, G., Crezee, H., Aebersold, D. M., Bodis, S., Ghadjar, P. (2015). Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. International Journal of Hyperthermia, 31(6), 609–614. https://doi.org/10.3109/02656736.2015.1040471
Crezee, H., van Leeuwen, C. M., Oei, A. L., Stalpers, L. J. A., Bel, A., Franken, N. A., & Kok, H. P. (2016). Thermoradiotherapy planning: Integration in routine clinical practice. International Journal of Hyperthermia, 32(1), 41–49. https://doi.org/10.3109/02656736.2015.1110757
Kaur, P., Hurwitz, M. D., Krishnan, S., & Asea, A. (2011). Combined hyperthermia and radiotherapy for the treatment of cancer. Cancers, 3(4), 3799–3823. https://doi.org/10.3390/cancers3043799
Oei, A. L., Vriend, L. E. M., Crezee, J., Franken, N. A. P., & Krawczyk, P. M. (2015). Effects of hyperthermia on DNA repair pathways: One treatment to inhibit them all. Radiation Oncology, 10(1). https://doi.org/10.1186/s13014-015-0462-0
Phase III Clinical Evidence. (n.d.). Retrieved June 11, 2019, from https://pyrexar.com/clinical/clinical-trials
Jha, S., Sharma, P. K., & Malviya, R. (2016). Hyperthermia: Role and Risk Factor for Cancer Treatment. Achievements in the Life Sciences, 10(2), 161–167. https://doi.org/10.1016/J.ALS.2016.11.004
Skitzki, J. J., Repasky, E. A., & Evans, S. S. (2009). Hyperthermia as an immunotherapy strategy for cancer. Current Opinion in Investigational Drugs (London, England : 2000), 10(6), 550. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828267
Peeken, J. C., Vaupel, P., & Combs, S. E. (2017). Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary? Frontiers in Oncology, 7, 132. https://doi.org/10.3389/fonc.2017.00132
